total 27. Whereas other key markets like US, South America and UK hasn't seen any shutdowns so-far. We believe, significant correction presents an opportunity to buy this stock at an attractive valuation at 11x FY21 estimates. We upgrade the stock to BUY (from Accumulate) with lowered fair value to Rs115 (from Rs153) led by earning cuts and lower 16x multiple (from 18x) to...